checkpoint inhibition in the treatment of mpns
Published 2 years ago • 152 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
2:05
checkpoint inhibitors: parallel management of the disease and immune-related toxicities
-
4:27
the role of immune checkpoint inhibitors in mds
-
1:53
toxicities and new immune checkpoint inhibitors
-
2:28
checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to allosct for hl
-
5:42
immune checkpoint inhibitors in mds and aml
-
2:53
immune checkpoint inhibitors in mds: the i4mds consortium
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
9:25
mgus diagnosis: a step-by-step approach
-
21:38
drawing the line: the rationale behind blood tube collection order
-
3:21
nox2: a potential immune checkpoint for inhibition in aml
-
4:59
checkpoint inhibitors in aml
-
1:59
topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
1:10
the sensitization of immune checkpoint inhibitors with subsequent chemotherapy in r/r hl
-
2:17
the impact of checkpoint inhibitor-based salvage regimens in patients with r/r hl undergoing autosct
-
1:58
impact of checkpoint inhibitor-based salvage regimens prior to allosct in r/r chl
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
2:15
cardiac biomarkers for immune checkpoint inhibitor-related myocarditis in cancer patients
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
3:37
challenges and unmet needs in mpns: transplant decision-making and the management of mpn-ap/bp